Suchergebnisse - (Person:"Ma, Ling")

PubPharm (22)

1

The Impact of mHealth-Based Continuous Care on Disease Knowledge, Treatment Compliance, and Serum Uric Acid Levels in Chinese Patients With Gout : Randomized Controlled Trial

enthalten in: JMIR mHealth and uHealth | 2024

von Wang, Y. | Chen, Y. | Song, Y. | +4

2

Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer

enthalten in: The New England journal of medicine | 2023

von Moore, K. | Angelergues, A. | Konecny, G. | +128

3

A phase I, randomized, ascending-dose study to assess safety, pharmacokinetics, and activity of GDC-8264, a RIP1 inhibitor, in healthy volunteers

enthalten in: Clinical and translational science | 2023

von Jones, N. | Kshirsagar, S. | Mohanan, V. | +11

4

Biofeedback physical regulation of hypertension based on acupoints : A clinical trial

enthalten in: Medicine | 2023

von Ma, L. | Zhang, Z. | Ma, L. | +4

5

Effects of neutrophil-to-lymphocyte ratio, serum calcium, and serum albumin on prognosis in patients with diabetic foot

enthalten in: International wound journal | 2023

von Xu, S. | Wang, Y. | Hu, Z. | +3

6

Pharmacokinetic Characteristics, Safety, and Tolerability of Telitacicept, an Injectable Recombinant Human B-Lymphocyte Stimulating Factor Receptor-Antibody Fusion Protein, in Healthy Chinese Subjects

enthalten in: Clinical pharmacology in drug development | 2022

von Xie, J. | Fan, X. | Su, Y. | +17

7

Rucaparib versus standard-of-care chemotherapy in patients with relapsed ovarian cancer and a deleterious BRCA1 or BRCA2 mutation (ARIEL4) : an international, open-label, randomised, phase 3 trial

enthalten in: The Lancet. Oncology | 2022

von Kristeleit, R. | Lisyanskaya, A. | Fedenko, A. | +22

CommentIn: Lancet Oncol. 2022 Apr;23(4):440-441. - PMID 35298905

8

Trilaciclib Prior to Chemotherapy in Patients with Metastatic Triple-Negative Breast Cancer : Final Efficacy and Subgroup Analysis from a Randomized Phase II Study

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Tan, A. | Wright, G. | Thummala, A. | +14

9

Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults : an interim analysis

enthalten in: Nature medicine | 2021

von Choi, A. | Koch, M. | Wu, K. | +19

CommentIn: Nat Med. 2021 Nov;27(11):1874-1875. - PMID 34764485

10

Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa) : A randomised, open-label phase II study

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von O'Shaughnessy, J. | Sousa, S. | Cruz, J. | +58